Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	1.21e-10	11	63	5	GO:0004523
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	5.21e-10	14	63	5	GO:0003964
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	5.20e-09	21	63	5	GO:0035613
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	1.07e-07	37	63	5	GO:0016891
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	1.23e-07	38	63	5	GO:0034061
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	3.30e-07	46	63	5	GO:0016893
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	5.01e-06	79	63	5	GO:0004521
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10	5.49e-06	37	63	4	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10	6.13e-06	38	63	4	GO:0070001
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 PARP14 ERVK-11	8.37e-06	152	63	6	GO:0016779
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	6.97e-05	136	63	5	GO:0004540
GeneOntologyMolecularFunction	endonuclease activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	6.97e-05	136	63	5	GO:0004519
GeneOntologyMolecularFunction	insulin-like growth factor II binding	IGFBP1 IGFBP4	2.71e-04	8	63	2	GO:0031995
GeneOntologyMolecularFunction	insulin-like growth factor I binding	IGFBP1 IGFBP4	7.47e-04	13	63	2	GO:0031994
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	8.08e-04	231	63	5	GO:0004518
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	ERVK-6 SULF2 SSH1 ERVK-8 CASR ERVK-7 ERVK-10 ERVK-11 CDC14A	9.19e-04	807	63	9	GO:0016788
GeneOntologyMolecularFunction	muscle alpha-actinin binding	MYPN PALLD	1.00e-03	15	63	2	GO:0051371
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	NTRK1 ROR2 FGFR1	1.14e-03	65	63	3	GO:0004714
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	1.42e-03	262	63	5	GO:0140097
GeneOntologyMolecularFunction	growth factor binding	IGFBP1 IGFBP4 NTRK1 FGFR1	1.49e-03	156	63	4	GO:0019838
GeneOntologyMolecularFunction	insulin-like growth factor binding	IGFBP1 IGFBP4	1.62e-03	19	63	2	GO:0005520
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 ERVK-8 CASP6 ERVK-7 ERVK-10 USP33	2.32e-03	430	63	6	GO:0004175
GeneOntologyMolecularFunction	amino acid:sodium symporter activity	SLC6A12 SLC6A5	2.37e-03	23	63	2	GO:0005283
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	NTRK1 ROR2 FGFR1	2.46e-03	85	63	3	GO:0019199
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ERVK-6 NTRK1 ROR2 ERVK-8 FGFR1 ERVK-7 ERVK-10 PARP14 ERVK-11	2.59e-03	938	63	9	GO:0016772
GeneOntologyMolecularFunction	cell adhesion molecule binding	MYPN CASR FGFR1 ITGA3 ITGB2 NOS2 PALLD	2.73e-03	599	63	7	GO:0050839
GeneOntologyMolecularFunction	amino acid:monoatomic cation symporter activity	SLC6A12 SLC6A5	3.77e-03	29	63	2	GO:0005416
GeneOntologyMolecularFunction	alpha-actinin binding	MYPN PALLD	4.29e-03	31	63	2	GO:0051393
GeneOntologyMolecularFunction	peptidase activity	ERVK-6 ERVK-8 USP43 CASP6 ERVK-7 ERVK-10 USP33	4.42e-03	654	63	7	GO:0008233
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC6A12 SLC6A5	5.45e-03	35	63	2	GO:0005343
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	3.10e-10	13	64	5	GO:0015074
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-8 USP43 ERVK-7 ERVK-10 ERVK-11	7.78e-09	48	64	6	GO:0000731
GeneOntologyBiologicalProcess	RNA-templated DNA biosynthetic process	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	5.91e-06	83	64	5	GO:0006278
GeneOntologyBiologicalProcess	DNA-templated DNA replication	ERVK-6 ERVK-8 FGFR1 ERVK-7 ERVK-10 ERVK-11	1.88e-05	178	64	6	GO:0006261
GeneOntologyBiologicalProcess	synapse organization	NF1 SSH1 NTRK1 ROR2 SLIT1 FGFR1 TANC1 REST ITGA3 PALLD	4.58e-05	685	64	10	GO:0050808
GeneOntologyBiologicalProcess	DNA biosynthetic process	ERVK-6 ERVK-8 USP43 ERVK-7 ERVK-10 ERVK-11	5.85e-05	218	64	6	GO:0071897
GeneOntologyBiologicalProcess	detection of mechanical stimulus	NTRK1 PJVK REST PKDREJ	8.68e-05	75	64	4	GO:0050982
GeneOntologyBiologicalProcess	sensory perception of mechanical stimulus	NTRK1 PJVK FGFR1 REST CDC14A SOD2	9.50e-05	238	64	6	GO:0050954
GeneOntologyBiologicalProcess	cell junction organization	NF1 STON1 SSH1 NTRK1 ROR2 SLIT1 FGFR1 TANC1 REST ITGA3 PALLD	1.84e-04	974	64	11	GO:0034330
GeneOntologyBiologicalProcess	detection of external stimulus	ABCA4 NTRK1 PJVK REST PKDREJ	2.00e-04	173	64	5	GO:0009581
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated immunity	C17orf99 TICAM1 PAXIP1 ITGB2 NOS2	2.11e-04	175	64	5	GO:0002705
GeneOntologyBiologicalProcess	detection of abiotic stimulus	ABCA4 NTRK1 PJVK REST PKDREJ	2.11e-04	175	64	5	GO:0009582
GeneOntologyBiologicalProcess	cellular response to low-density lipoprotein particle stimulus	TICAM1 CASR ITGB2	2.40e-04	39	64	3	GO:0071404
GeneOntologyBiologicalProcess	response to lipoprotein particle	TICAM1 CASR ITGB2	2.59e-04	40	64	3	GO:0055094
GeneOntologyBiologicalProcess	mechanoreceptor differentiation	NTRK1 PJVK FGFR1 REST	3.07e-04	104	64	4	GO:0042490
GeneOntologyBiologicalProcess	cellular response to lipoprotein particle stimulus	TICAM1 CASR ITGB2	3.22e-04	43	64	3	GO:0071402
GeneOntologyBiologicalProcess	sensory perception of sound	PJVK FGFR1 REST CDC14A SOD2	3.73e-04	198	64	5	GO:0007605
GeneOntologyBiologicalProcess	nitric oxide biosynthetic process	TICAM1 ITGB2 NOS2 SOD2	4.07e-04	112	64	4	GO:0006809
GeneOntologyBiologicalProcess	DNA replication	ERVK-6 ERVK-8 FGFR1 ERVK-7 ERVK-10 ERVK-11	4.10e-04	312	64	6	GO:0006260
GeneOntologyBiologicalProcess	postsynapse organization	NF1 SSH1 ROR2 FGFR1 TANC1 ITGA3	4.17e-04	313	64	6	GO:0099173
GeneOntologyBiologicalProcess	tangential migration from the subventricular zone to the olfactory bulb	SLIT1 FGFR1	4.20e-04	10	64	2	GO:0022028
GeneOntologyBiologicalProcess	neuron development	NF1 NTRK1 PJVK ROR2 MYPN SLIT1 CASP6 FGFR1 REST ITGA3 PALLD SOD2 USP33	4.74e-04	1463	64	13	GO:0048666
GeneOntologyBiologicalProcess	olfactory bulb interneuron development	SLIT1 FGFR1	5.12e-04	11	64	2	GO:0021891
GeneOntologyBiologicalProcess	neuron projection development	NF1 NTRK1 PJVK ROR2 MYPN SLIT1 CASP6 FGFR1 REST ITGA3 PALLD USP33	5.21e-04	1285	64	12	GO:0031175
GeneOntologyBiologicalProcess	nitric oxide metabolic process	TICAM1 ITGB2 NOS2 SOD2	5.46e-04	121	64	4	GO:0046209
Domain	IGFBP1-6	IGFBP1 IGFBP4	1.46e-04	6	59	2	IPR009168
Domain	IGFBP_1-6_chordata	IGFBP1 IGFBP4	1.46e-04	6	59	2	IPR022321
Domain	Insulin_GF-bd_Cys-rich_CS	IGFBP1 IGFBP4	5.30e-04	11	59	2	IPR017891
Domain	IGFBP_N_1	IGFBP1 IGFBP4	6.34e-04	12	59	2	PS00222
Domain	EGF_1	ATRAID SLIT1 LRP1B ITGB2 SSPOP	1.25e-03	255	59	5	PS00022
Domain	TY	IGFBP1 IGFBP4	1.29e-03	17	59	2	SM00211
Domain	-	IGFBP1 IGFBP4	1.29e-03	17	59	2	4.10.800.10
Domain	THYROGLOBULIN_1_2	IGFBP1 IGFBP4	1.29e-03	17	59	2	PS51162
Domain	Thyroglobulin_1	IGFBP1 IGFBP4	1.29e-03	17	59	2	IPR000716
Domain	Thyroglobulin_1	IGFBP1 IGFBP4	1.29e-03	17	59	2	PF00086
Domain	THYROGLOBULIN_1_1	IGFBP1 IGFBP4	1.29e-03	17	59	2	PS00484
Domain	NA_NEUROTRAN_SYMP_2	SLC6A12 SLC6A5	1.45e-03	18	59	2	PS00754
Domain	CTCK_1	SLIT1 SSPOP	1.45e-03	18	59	2	PS01185
Domain	IB	IGFBP1 IGFBP4	1.45e-03	18	59	2	SM00121
Domain	EGF_2	ATRAID SLIT1 LRP1B ITGB2 SSPOP	1.48e-03	265	59	5	PS01186
Domain	Growth_fac_rcpt_	IGFBP1 IGFBP4 SLIT1 LRP1B	1.49e-03	156	59	4	IPR009030
Domain	SNF	SLC6A12 SLC6A5	1.62e-03	19	59	2	PF00209
Domain	NA_NEUROTRAN_SYMP_1	SLC6A12 SLC6A5	1.62e-03	19	59	2	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A12 SLC6A5	1.62e-03	19	59	2	PS50267
Domain	Na/ntran_symport	SLC6A12 SLC6A5	1.62e-03	19	59	2	IPR000175
Domain	IGFBP-like	IGFBP1 IGFBP4	1.80e-03	20	59	2	IPR000867
Domain	IGFBP	IGFBP1 IGFBP4	1.80e-03	20	59	2	PF00219
Domain	IGFBP_N_2	IGFBP1 IGFBP4	1.80e-03	20	59	2	PS51323
Domain	TyrKc	NTRK1 ROR2 FGFR1	2.72e-03	88	59	3	SM00219
Domain	Tyr_kinase_cat_dom	NTRK1 ROR2 FGFR1	2.72e-03	88	59	3	IPR020635
Domain	Integrin_dom	ITGA3 ITGB2	2.81e-03	25	59	2	IPR032695
Domain	Cys_knot_C	SLIT1 SSPOP	2.81e-03	25	59	2	IPR006207
Domain	CTCK_2	SLIT1 SSPOP	2.81e-03	25	59	2	PS01225
Domain	Ig_I-set	ROR2 MYPN FGFR1 PALLD	3.05e-03	190	59	4	IPR013098
Domain	I-set	ROR2 MYPN FGFR1 PALLD	3.05e-03	190	59	4	PF07679
Domain	PROTEIN_KINASE_TYR	NTRK1 ROR2 FGFR1	3.58e-03	97	59	3	PS00109
Domain	Tyr_kinase_AS	NTRK1 ROR2 FGFR1	3.58e-03	97	59	3	IPR008266
Domain	Spectrin/alpha-actinin	SPTBN5 EVPLL	4.58e-03	32	59	2	IPR018159
Domain	SPEC	SPTBN5 EVPLL	4.58e-03	32	59	2	SM00150
Domain	TYR_PHOSPHATASE_DUAL	SSH1 CDC14A	5.16e-03	34	59	2	PS50054
Domain	TYR_PHOSPHATASE_DUAL_dom	SSH1 CDC14A	5.46e-03	35	59	2	IPR020422
Domain	DSPc	SSH1 CDC14A	5.46e-03	35	59	2	SM00195
Domain	IGc2	ROR2 MYPN FGFR1 PALLD	6.47e-03	235	59	4	SM00408
Domain	EGF_3	ATRAID SLIT1 LRP1B SSPOP	6.47e-03	235	59	4	PS50026
Domain	Ig_sub2	ROR2 MYPN FGFR1 PALLD	6.47e-03	235	59	4	IPR003598
Domain	LDLR_class-A_CS	LRP1B SSPOP	7.08e-03	40	59	2	IPR023415
Domain	Dual-sp_phosphatase_cat-dom	SSH1 CDC14A	7.43e-03	41	59	2	IPR000340
Domain	DSPc	SSH1 CDC14A	7.43e-03	41	59	2	PF00782
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10	2.37e-08	4	64	3	10469592
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-8 ERVK-7 ERVK-10 ERVK-11	8.71e-07	94	64	5	21542922
Pubmed	The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.	IGFBP1 NTRK1 FGFR1 ITGA3 ITGB2	1.13e-06	99	64	5	19730683
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	NTRK1 FGFR1 ITGA3 LRP1B ITGB2	1.24e-06	101	64	5	23382219
Pubmed	The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology.	NOS2 SOD2	3.33e-06	2	64	2	37660159
Pubmed	Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis.	IGFBP1 IGFBP4	3.33e-06	2	64	2	16973813
Pubmed	The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.	NTRK1 SOD2	3.33e-06	2	64	2	24736663
Pubmed	Transient hyperoxic reoxygenation reduces cytochrome C oxidase activity by increasing superoxide dismutase and nitric oxide.	NOS2 SOD2	3.33e-06	2	64	2	20086011
Pubmed	Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.	NF1 FGFR1	3.33e-06	2	64	2	27862886
Pubmed	Manganese influx and expression of ZIP8 is essential in primary myoblasts and contributes to activation of SOD2.	SLC39A8 SOD2	3.33e-06	2	64	2	31086870
Pubmed	Assessing the range of kinase autoinhibition mechanisms in the insulin receptor family.	NTRK1 ROR2	3.33e-06	2	64	2	22992069
Pubmed	Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.	NF1 FGFR1	9.99e-06	3	64	2	31250151
Pubmed	Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.	IGFBP1 IGFBP4	9.99e-06	3	64	2	16924115
Pubmed	FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.	NF1 FGFR1	9.99e-06	3	64	2	25616962
Pubmed	Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone.	NF1 FGFR1	9.99e-06	3	64	2	30549028
Pubmed	The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4.	NOS2 STAT4	9.99e-06	3	64	2	11207258
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-11	9.99e-06	3	64	2	9971820
Pubmed	Expression of Mn-SOD, iNOS and eNOS mRNAs in osteoblasts from the maxilla of osteopetrotic mice.	NOS2 SOD2	9.99e-06	3	64	2	22783967
Pubmed	Genetic polymorphisms affecting antioxidant enzymes are present in tympanosclerosis patients.	NOS2 SOD2	9.99e-06	3	64	2	27534583
Pubmed	Nitric-oxide synthase-2 linkage to focal adhesion kinase in neutrophils influences enzyme activity and β2 integrin function.	ITGB2 NOS2	9.99e-06	3	64	2	23297409
Pubmed	Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells.	NOS2 SOD2	9.99e-06	3	64	2	18160224
Pubmed	CaSR stimulates secretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucrase-isomaltase using Ror2 on intestinal epithelia.	ROR2 CASR	2.00e-05	4	64	2	18703641
Pubmed	Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism.	TICAM1 NOS2	2.00e-05	4	64	2	19644121
Pubmed	Selective developmental regulation of gene expression for insulin-like growth factor-binding proteins in mouse spinal cord.	IGFBP1 IGFBP4	2.00e-05	4	64	2	10888943
Pubmed	Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development.	IGFBP1 IGFBP4	2.00e-05	4	64	2	7505465
Pubmed	Involvement of α-klotho, fibroblast growth factor-, vitamin-D- and calcium-sensing receptor in 53 patients with primary hyperparathyroidism.	CASR FGFR1	2.00e-05	4	64	2	23334987
Pubmed	Importance of C/EBPβ binding and histone acetylation status in the promoter regions for induction of IGFBP-1, PRL, and Mn-SOD by cAMP in human endometrial stromal cells.	IGFBP1 SOD2	2.00e-05	4	64	2	24248464
Pubmed	Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.	IGFBP1 IGFBP4	2.00e-05	4	64	2	9408744
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10	2.00e-05	4	64	2	7983737
Pubmed	Nitric oxide synthase and superoxide dismutase gene polymorphisms in Behçet disease.	NOS2 SOD2	2.00e-05	4	64	2	17296902
Pubmed	Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent.	NOS2 STAT4	2.00e-05	4	64	2	12555666
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7	3.32e-05	5	64	2	12629516
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7	3.32e-05	5	64	2	11401426
Pubmed	Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.	NOS2 STAT4	3.32e-05	5	64	2	17517868
Pubmed	Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene.	IGFBP1 IGFBP4	3.32e-05	5	64	2	17255210
Pubmed	Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells.	NOS2 SOD2	3.32e-05	5	64	2	14684357
Pubmed	Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability.	SSH1 CDC14A	3.32e-05	5	64	2	20477815
Pubmed	Structure and chromosomal mapping of the TNF-alpha inducible endothelial protein 1 (Edp1) gene in the mouse.	NF1 NOS2	3.32e-05	5	64	2	9804998
Pubmed	Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients.	NOS2 SOD2	3.32e-05	5	64	2	19242068
Pubmed	Polymorphisms in innate immunity genes and risk of childhood leukemia.	TICAM1 ITGB2 NOS2 STAT4 SOD2	3.99e-05	206	64	5	20438785
Pubmed	Risk of meningioma and common variation in genes related to innate immunity.	TICAM1 ITGB2 NOS2 STAT4 SOD2	4.08e-05	207	64	5	20406964
Pubmed	Common variation in genes related to innate immunity and risk of adult glioma.	TICAM1 ITGB2 NOS2 STAT4 SOD2	4.17e-05	208	64	5	19423540
Pubmed	Insulin-like growth factor binding proteins are transcribed by preimplantation mouse embryos.	IGFBP1 IGFBP4	4.98e-05	6	64	2	7511095
Pubmed	Gene expression of the six insulin-like growth factor binding proteins in the mouse conceptus during mid- and late gestation.	IGFBP1 IGFBP4	4.98e-05	6	64	2	7684980
Pubmed	Insulin-like growth factor (IGF)-binding proteins in serum--do they have additional roles besides modulating the endocrine IGF actions?	IGFBP1 IGFBP4	4.98e-05	6	64	2	8923818
Pubmed	Peritoneal tissue-resident macrophages are metabolically poised to engage microbes using tissue-niche fuels.	TICAM1 NOS2	4.98e-05	6	64	2	29234000
Pubmed	Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.	IGFBP1 IGFBP4	4.98e-05	6	64	2	12933651
Pubmed	Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels.	ITGA3 ITGB2	4.98e-05	6	64	2	22711877
Pubmed	Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice.	IGFBP1 IGFBP4	4.98e-05	6	64	2	7510770
Pubmed	Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.	IGFBP1 IGFBP4	4.98e-05	6	64	2	7679139
Pubmed	Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo.	IGFBP1 IGFBP4	4.98e-05	6	64	2	10579362
Pubmed	Simultaneous detection of multiple gene expression in mouse and human individual preimplantation embryos.	IGFBP1 IGFBP4	4.98e-05	6	64	2	9093203
Pubmed	Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins.	IGFBP1 IGFBP4	4.98e-05	6	64	2	10744620
Pubmed	Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene.	IGFBP1 IGFBP4	4.98e-05	6	64	2	10976924
Pubmed	cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins.	IGFBP1 IGFBP4	4.98e-05	6	64	2	7529732
Pubmed	Temporal control of a dendritogenesis-linked gene via REST-dependent regulation of nuclear factor I occupancy.	NF1 REST	4.98e-05	6	64	2	21270437
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	NTRK1 ROR2 FGFR1	5.59e-05	40	64	3	30898150
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	B3GNT9 SULF2 NF1 IGFBP4 P2RX5 CNPY4 ROR2 ITGA3 LRP1B PALLD	6.46e-05	1201	64	10	35696571
Pubmed	Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival.	TICAM1 STAT4	6.96e-05	7	64	2	18211965
Pubmed	Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells.	NOS2 STAT4	6.96e-05	7	64	2	26595887
Pubmed	Signaling events leading to peroxiredoxin 5 up-regulation in immunostimulated macrophages.	TICAM1 NOS2	6.96e-05	7	64	2	19540914
Pubmed	Transferrin is an insulin-like growth factor-binding protein-3 binding protein.	IGFBP1 IGFBP4	6.96e-05	7	64	2	11297622
Pubmed	High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.	IGFBP1 IGFBP4 NTRK1 ROR2 CASR FGFR1	7.50e-05	383	64	6	19453261
Pubmed	Expression patterns of beta1-related alpha integrin subunits in murine lens during embryonic development and wound healing.	ITGA3 ITGB2	9.27e-05	8	64	2	15370361
Pubmed	The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes.	ITGA3 ITGB2	9.27e-05	8	64	2	10906324
Pubmed	Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling.	TICAM1 NOS2	9.27e-05	8	64	2	25628461
Pubmed	Dual branch-promoting and branch-repelling actions of Slit/Robo signaling on peripheral and central branches of developing sensory axons.	NTRK1 SLIT1	9.27e-05	8	64	2	17581972
Pubmed	Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies.	MYPN PALLD	9.27e-05	8	64	2	11309420
Pubmed	Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins.	IGFBP1 IGFBP4	9.27e-05	8	64	2	10407151
Pubmed	The expression of insulin-like growth factor and insulin-like growth factor binding protein mRNAs in mouse placenta.	IGFBP1 IGFBP4	9.27e-05	8	64	2	16338473
Pubmed	Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins.	TICAM1 ITGB2	1.19e-04	9	64	2	20362473
Pubmed	Single-cell analysis of murine long-term hematopoietic stem cells reveals distinct patterns of gene expression during fetal migration.	CASR ITGB2	1.19e-04	9	64	2	22276210
Pubmed	Gene expression of the insulin-like growth factor system during mouse kidney development.	IGFBP1 IGFBP4	1.19e-04	9	64	2	9324049
Pubmed	Genetic modifiers of EGFR dependence in non-small cell lung cancer.	NTRK1 FGFR1	1.19e-04	9	64	2	25512530
Pubmed	mRNA expression patterns of the IGF system during mouse limb bud development, determined by whole mount in situ hybridization.	IGFBP1 IGFBP4	1.19e-04	9	64	2	9685224
Pubmed	mRNA and protein localization of the IGF system during mouse embryonic development in areas with apoptosis.	IGFBP1 IGFBP4	1.19e-04	9	64	2	10502456
Pubmed	L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.	SLC6A12 NTRK1 SLC6A5 CASR	1.44e-04	143	64	4	20424473
Pubmed	FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.	NTRK1 FGFR1	1.49e-04	10	64	2	10629055
Pubmed	A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.	TICAM1 STAT4	1.49e-04	10	64	2	23334414
Pubmed	Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.	NOS2 SOD2	1.49e-04	10	64	2	16543247
Pubmed	Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.	NOS2 SOD2	1.49e-04	10	64	2	17149600
Pubmed	IGFs increase enamel formation by inducing expression of enamel mineralizing specific genes.	IGFBP1 IGFBP4	1.81e-04	11	64	2	15721138
Pubmed	Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis.	IGFBP1 IGFBP4	1.81e-04	11	64	2	7750499
Pubmed	Dysregulated cell signalling and reduced satellite cell potential in ageing muscle.	SULF2 FGFR1	2.17e-04	12	64	2	31647919
Pubmed	Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.	TICAM1 ITGB2	2.17e-04	12	64	2	16116224
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-8	2.17e-04	12	64	2	14557543
Pubmed	Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.	IGFBP1 IGFBP4 ROR2	2.29e-04	64	64	3	24431302
Pubmed	Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels.	ITGA3 ITGB2	2.57e-04	13	64	2	20563599
Pubmed	Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis.	IGFBP1 IGFBP4	2.57e-04	13	64	2	35741102
Pubmed	YAC/P1 contigs defining the location of 56 microsatellite markers and several genes across a 3.4-cM interval on mouse chromosome 11.	NF1 NOS2	2.57e-04	13	64	2	7626882
Pubmed	Phosphatidylserine Ameliorates Neurodegenerative Symptoms and Enhances Axonal Transport in a Mouse Model of Familial Dysautonomia.	NTRK1 REST	2.99e-04	14	64	2	27997532
Pubmed	Expression of insulin-like growth factor binding proteins during mouse cochlear development.	IGFBP1 IGFBP4	2.99e-04	14	64	2	23813480
Pubmed	Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses.	TICAM1 ITGB2	2.99e-04	14	64	2	26453377
Pubmed	Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors.	NOS2 SOD2	3.45e-04	15	64	2	19505917
Pubmed	Spatially distinct functions of PAX6 and NKX2.2 during gliogenesis in the ventral spinal cord.	SULF2 SLIT1	3.93e-04	16	64	2	19258013
Pubmed	A functional circuit formed by the autonomic nerves and myofibroblasts controls mammalian alveolar formation for gas exchange.	NTRK1 ROR2	3.93e-04	16	64	2	35714603
Pubmed	Nebulette knockout mice have normal cardiac function, but show Z-line widening and up-regulation of cardiac stress markers.	MYPN PALLD	3.93e-04	16	64	2	25987543
Pubmed	Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.	NF1 NTRK1	3.93e-04	16	64	2	28637693
Pubmed	Sensory and spinal inhibitory dorsal midline crossing is independent of Robo3.	NTRK1 SLIT1	4.45e-04	17	64	2	26257608
Pubmed	Proper development of relay somatic sensory neurons and D2/D4 interneurons requires homeobox genes Rnx/Tlx-3 and Tlx-1.	NTRK1 SLIT1	4.45e-04	17	64	2	12023301
Cytoband	Ensembl 112 genes in cytogenetic band chr7q36	ZNF425 PAXIP1 SSPOP	1.45e-03	159	64	3	chr7q36
GeneFamily	Insulin like growth factor binding proteins	IGFBP1 IGFBP4	8.24e-05	6	43	2	1065
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	NTRK1 ROR2 FGFR1	1.16e-04	40	43	3	321
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	ROR2 MYPN FGFR1 PALLD	5.70e-04	161	43	4	593
GeneFamily	Ubiquitin specific peptidases	USP43 USP33	7.84e-03	56	43	2	366
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP	ABCA4 TICAM1 FNDC3A SLC39A8 STAT4 SOD2	5.89e-06	200	59	6	M5211
Coexpression	GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	CASS4 TBC1D16 SLC6A12 SULF2 ITGB2 CDC14A	5.89e-06	200	59	6	M7168
Coexpression	DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	NF1 NTRK1 LRP1B	2.71e-05	26	59	3	M16488
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	SLC6A12 REST PARP14 MGA CDC14A	3.15e-05	161	59	5	M9446
Coexpression	JNK_DN.V1_DN	ABCA4 STON1 SLC6A5 SERPINF2 ITGB2	6.92e-05	190	59	5	M2745
Coexpression	MOTAMED_RESPONSE_TO_ANDROGEN_UP	SSH1 SSPOP	7.43e-05	6	59	2	M1148
Coexpression	GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN	NF1 STON1 RAB22A FGFR1 SERPINF2	8.02e-05	196	59	5	M7672
Coexpression	GSE17721_0.5H_VS_4H_LPS_BMDC_DN	TANC1 PARP14 NOS2 PALLD SLC39A8	8.82e-05	200	59	5	M4073
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	SSH1 FNDC3A FGFR1 SLC39A8 STAT4 SOD2	2.57e-07	199	59	6	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	droplet-Kidney-nan-3m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 ZBTB37 PJVK SSPOP SLC39A8	3.08e-06	170	59	5	dd48fd3c5c67eb71183981f42975a538f12077c3
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 IGFBP1 PJVK ROR2 SLC39A8	3.17e-06	171	59	5	8e7223ba447947cdf4e1c82a52fd90439cf3d8f6
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ROR2 MYPN TANC1 PALLD STAT4	5.87e-06	194	59	5	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	Myeloid-Myeloid-F\|Myeloid / shred on cell class and cell subclass (v4)	ITGA3 PARP14 NOS2 SOD2	5.46e-05	156	59	4	d6317843ae5c5749452889e768c187a9d9e8c7fe
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC6A12 P2RX5 CDC14A STAT4	6.94e-05	166	59	4	ceb0a48c0d853448fd45ac31dde046df9a178571
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 PJVK ROR2 SLC39A8	7.11e-05	167	59	4	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SULF2 PJVK ITGB2 STAT4	7.11e-05	167	59	4	aef22535a76e93472bcedacbb2c6991f3c9c8cd5
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 PJVK SSPOP SLC39A8	7.11e-05	167	59	4	40d102e01ccbc7262d00fafd59ca5234909009cb
ToppCell	droplet-Kidney-nan-18m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 PJVK ROR2 SLC39A8	7.44e-05	169	59	4	f00741203efa0b948db7223ee8c19bdd0918258a
ToppCell	droplet-Kidney-nan-21m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D16 PJVK ROR2 SLC39A8	7.79e-05	171	59	4	007f148f4611ea1826edfa9f91ced36541ad9f5a
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A12 IGFBP4 TADA2B TANC1	7.79e-05	171	59	4	fea6ef6bbfebea2dd0f0360c7db7a5e858f15958
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGFBP4 ROR2 FGFR1 PALLD	7.79e-05	171	59	4	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A12 IGFBP4 TADA2B TANC1	7.79e-05	171	59	4	f15594fd4d709920733de9376a391dedc62b65de
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGFBP4 ROR2 FGFR1 PALLD	7.79e-05	171	59	4	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB37 ABCA4 SLIT1 SSPOP	8.71e-05	176	59	4	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB37 ABCA4 SLIT1 SSPOP	8.71e-05	176	59	4	aa1bada2175d8370fc71939a607407155259d195
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175\|Adult / Lineage, Cell type, age group and donor	SULF2 IGFBP4 LRP1B SOD2	8.90e-05	177	59	4	c9f269765c7d5d29caab75910e51645606ed562e
ToppCell	Severe-Myeloid-mDC\|Severe / Condition, Lineage, Cell class and cell subclass	SULF2 C17orf99 SERPINF2 PALLD	9.70e-05	181	59	4	00f2949b609ac21bd2da6fd8f685739eeb2f48ad
ToppCell	Severe-Myeloid-mDC-\|Severe / Condition, Lineage, Cell class and cell subclass	SULF2 C17orf99 SERPINF2 PALLD	9.70e-05	181	59	4	51ded98c76ec35ab1d24ac3ab98280381daa9831
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SULF2 FGFR1 TANC1 CDC14A	9.91e-05	182	59	4	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SULF2 FGFR1 TANC1 CDC14A	9.91e-05	182	59	4	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	RA-17._Lymphocyte\|World / Chamber and Cluster_Paper	CASS4 ITGB2 CDC14A STAT4	1.01e-04	183	59	4	6397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A12 CHDH SERPINF2 SLC39A8	1.03e-04	184	59	4	9434731f651820b05335085582960f08fbf895de
ToppCell	(7)_DC_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SLC6A12 C17orf99 ROR2 PALLD	1.03e-04	184	59	4	b89871a3e36fde6daa68daf116f8c8d587554c0f
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CASS4 B3GNT9 IGFBP4 PALLD	1.06e-04	185	59	4	a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SLC6A12 SULF2 SLC39A8 SOD2	1.08e-04	186	59	4	0dce13e15c3bf32610bf2dad31253b52a39cff87
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGFBP4 ROR2 CDC14A STAT4	1.10e-04	187	59	4	f1ba41f2ec703251a81c46e08d45e70210f298e7
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A12 IGFBP4 NTRK1 FGFR1	1.10e-04	187	59	4	7beba2a5d5978f2ae7d8bde10815705cf2572211
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYPN TANC1 PALLD STAT4	1.12e-04	188	59	4	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	NF1 PARP14 CDC14A STAT4	1.12e-04	188	59	4	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SSH1 ROR2 PAXIP1 PALLD	1.12e-04	188	59	4	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SSH1 ROR2 PAXIP1 PALLD	1.12e-04	188	59	4	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SSH1 ROR2 PAXIP1 PALLD	1.12e-04	188	59	4	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SULF2 ABCA4 USP43 FGFR1	1.12e-04	188	59	4	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	Control-Myeloid-MoAM1\|Control / Disease group,lineage and cell class （2021.01.30）	SULF2 SSPOP SLC39A8 SOD2	1.15e-04	189	59	4	55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba
ToppCell	IPF-Endothelial-VE_Capillary_A\|World / Disease state, Lineage and Cell class	IGFBP4 TANC1 ITGA3 NOS2	1.15e-04	189	59	4	ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYPN FNDC3A TANC1 PALLD	1.15e-04	189	59	4	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SULF2 IGFBP4 SSPOP SOD2	1.17e-04	190	59	4	5c8aa310886c64ee5dce4ba46a3dd178da549529
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MYPN FNDC3A TANC1 PALLD	1.17e-04	190	59	4	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SULF2 IGFBP4 SSPOP SOD2	1.17e-04	190	59	4	4b4fe93061c87605dddf5bec94fa07c749c722aa
ToppCell	10x5'-GI_small-bowel-Myeloid_Dendritic-migDC\|GI_small-bowel / Manually curated celltypes from each tissue	SLC6A12 SULF2 SERPINF2 PALLD	1.17e-04	190	59	4	e9b2c201d07f0cb87fa60005251c9e1663e246ed
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CASS4 B3GNT9 IGFBP4 PALLD	1.19e-04	191	59	4	a05e9a7eb137d804570dd7d8905975d735738767
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	MYPN TANC1 PALLD STAT4	1.19e-04	191	59	4	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	15-Trachea-Epithelial-Submucosal_gland_basal\|Trachea / Age, Tissue, Lineage and Cell class	IGFBP4 CHDH ROR2 FGFR1	1.19e-04	191	59	4	409e12d2bb26b6d2ed025304ca6ace07df16638a
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CASS4 SULF2 ROR2 PALLD	1.22e-04	192	59	4	2c69f3f388b69fb1c1968c923cdbab90658883dd
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CASS4 SULF2 ROR2 PALLD	1.22e-04	192	59	4	d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FGFR1 SERPINF2 LRP1B SOD2	1.22e-04	192	59	4	11867f30f0b420c18cb0b34d3990237aa737a0e8
ToppCell	droplet-Heart-nan-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.24e-04	193	59	4	0ca0439dfdcb2361ca8d1015fb874a5b5c635d31
ToppCell	droplet-Heart-nan-24m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.24e-04	193	59	4	d08919db9601941569b9a143dad4d8e6f56a4389
ToppCell	(5)_Epithelial_cells-(5)_Epi_basal\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	IGFBP4 CHDH SERPINF2 ITGB2	1.27e-04	194	59	4	b887b2ff19b76bd93c67f9a24762efae816efd45
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.27e-04	194	59	4	ce32e60bcea1b8baf496ce9050832bc8c77d8434
ToppCell	droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.27e-04	194	59	4	a1dc157148885cc8d3685ac81a1f4e3562aeecc9
ToppCell	droplet-Heart-nan-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.27e-04	194	59	4	20a0439fa02c5f8107612e34c7ab54120b9b8573
ToppCell	RA\|World / Chamber and Cluster_Paper	ROR2 FGFR1 SLC39A8 STAT4	1.27e-04	194	59	4	08f0afbb68a63150fbe107a5337299081c3f69e4
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	SLC6A12 TANC1 ITGA3 PARP14	1.27e-04	194	59	4	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MYPN TANC1 PALLD STAT4	1.27e-04	194	59	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	SLC6A12 TANC1 ITGA3 PARP14	1.27e-04	194	59	4	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGFBP1 IGFBP4 ITGA3 PALLD	1.27e-04	194	59	4	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASS4 IGFBP4 FGFR1 PALLD	1.29e-04	195	59	4	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASS4 B3GNT9 IGFBP4 PALLD	1.29e-04	195	59	4	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.29e-04	195	59	4	613bea20c3d82c22a6af4c1a668af6fcf11fec0a
ToppCell	droplet-Heart-nan-18m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.29e-04	195	59	4	9ffabd831c2a0de3597f328e83db7ee259cb0ccc
ToppCell	facs-Heart-LA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.29e-04	195	59	4	79a6e8e6de040ff07539e8901fc407363a50e355
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	SULF2 ROR2 FGFR1 RUSC2	1.29e-04	195	59	4	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A12 IGFBP4 ITGA3 PARP14	1.29e-04	195	59	4	633c7668fe365f7b0f7851cdc442d5dd89c454e2
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASS4 B3GNT9 IGFBP4 PALLD	1.29e-04	195	59	4	8aa753934debffe5ae4b5eecb6b50c46d17cc3ec
ToppCell	ASK428-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	SULF2 STON1 IGFBP4 ROR2	1.29e-04	195	59	4	c750602c765a51075ba6ede78e3ba80b62374481
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CASS4 IGFBP4 FGFR1 PALLD	1.29e-04	195	59	4	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SPTBN5 IGFBP4 MYPN	1.30e-04	74	59	3	08874e430b4c9fcb2c1758c4178cb0c45671b125
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.32e-04	196	59	4	ad1838dabd043cb140260843e3527d8c7d58850e
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT9 SULF2 IGFBP4 FGFR1	1.32e-04	196	59	4	cbc15c0769016fe9972445169029bd8d14a7e6ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGFBP4 ROR2 FGFR1 PALLD	1.34e-04	197	59	4	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CASS4 ROR2 TANC1 PALLD	1.34e-04	197	59	4	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	IGFBP4 ROR2 FGFR1 PALLD	1.37e-04	198	59	4	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	Sepsis-Bac-SEP-Lymphocyte-T/NK-MAIT\|Bac-SEP / Disease, condition lineage and cell class	SPTBN5 CHDH ITGA3 STAT4	1.37e-04	198	59	4	aea3654b16785aa9857ed646bd0d0dc9724df364
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB37 PARP14 CDC14A STAT4	1.40e-04	199	59	4	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SULF2 IGFBP4 PARP14 SOD2	1.40e-04	199	59	4	fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CASS4 P2RX5 ITGB2 STAT4	1.40e-04	199	59	4	5fc9bd5740e2e4d657c8c3dd26567db9a6da5af8
Disease	Malignant neoplasm of breast	SULF2 ABCA4 NF1 TICAM1 SLC6A5 FGFR1 PKDREJ NOS2 STAT4 SOD2	3.57e-05	1074	57	10	C0006142
Disease	Bonnevie-Ullrich Syndrome	NOS2 SOD2	3.65e-05	5	57	2	C1527168
Disease	Turner Syndrome	NOS2 SOD2	3.65e-05	5	57	2	C0041408
Disease	Gonadal Dysgenesis, 45,X	NOS2 SOD2	3.65e-05	5	57	2	C0242526
Disease	pancreatic cancer (is_marker_for)	NTRK1 NOS2 PALLD SOD2	4.44e-05	101	57	4	DOID:1793 (is_marker_for)
Disease	Secondary Biliary Cholangitis	IGFBP1 NOS2 STAT4	7.44e-05	42	57	3	C0238065
Disease	Biliary cirrhosis	IGFBP1 NOS2 STAT4	7.44e-05	42	57	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	IGFBP1 NOS2 STAT4	7.44e-05	42	57	3	C4551595
Disease	colitis (biomarker_via_orthology)	NTRK1 SI NOS2	7.44e-05	42	57	3	DOID:0060180 (biomarker_via_orthology)
Disease	Endotoxemia	NOS2 SOD2	1.02e-04	8	57	2	C0376618
Disease	Primary biliary cirrhosis	IGFBP1 NOS2 STAT4	1.04e-04	47	57	3	C0008312
Disease	Marfan Syndrome, Type I	NOS2 SOD2	1.31e-04	9	57	2	C4721845
Disease	retinal detachment (biomarker_via_orthology)	NTRK1 FGFR1	1.31e-04	9	57	2	DOID:5327 (biomarker_via_orthology)
Disease	Oxidative Phosphorylation Deficiencies	NOS2 SOD2	1.31e-04	9	57	2	C0949856
Disease	Mitochondrial Respiratory Chain Deficiencies	NOS2 SOD2	1.31e-04	9	57	2	C0949857
Disease	Electron Transport Chain Deficiencies, Mitochondrial	NOS2 SOD2	1.31e-04	9	57	2	C0949855
Disease	psoriasis	MYPN SLIT1 CASR NOS2 RUSC2	1.85e-04	273	57	5	EFO_0000676
Disease	Marfan Syndrome	NOS2 SOD2	1.99e-04	11	57	2	C0024796
Disease	asthma (biomarker_via_orthology)	NTRK1 NOS2 STAT4	2.06e-04	59	57	3	DOID:2841 (biomarker_via_orthology)
Disease	myocardial infarction (biomarker_via_orthology)	CASR ITGA3 NOS2 SOD2	2.63e-04	160	57	4	DOID:5844 (biomarker_via_orthology)
Disease	diabetic angiopathy (is_implicated_in)	IGFBP1 SOD2	2.82e-04	13	57	2	DOID:11713 (is_implicated_in)
Disease	abdominal aortic aneurysm (biomarker_via_orthology)	NOS2 SOD2	3.29e-04	14	57	2	DOID:7693 (biomarker_via_orthology)
Disease	Manganese Poisoning	NOS2 SLC39A8	3.29e-04	14	57	2	C0677050
Disease	Malignant Glioma	NF1 NTRK1 FGFR1	3.41e-04	70	57	3	C0555198
Disease	mixed gliomas	NF1 NTRK1 FGFR1	3.41e-04	70	57	3	C0259783
Disease	hepatocellular carcinoma (is_implicated_in)	FGFR1 LRP1B STAT4 SOD2	4.20e-04	181	57	4	DOID:684 (is_implicated_in)
Disease	idiopathic scoliosis (implicated_via_orthology)	SSPOP SLC39A8	4.32e-04	16	57	2	DOID:0060250 (implicated_via_orthology)
Disease	Nonsyndromic genetic hearing loss	PJVK REST CDC14A	4.35e-04	76	57	3	cv:C5680182
Disease	Necrotizing Enterocolitis	NOS2 SOD2	4.89e-04	17	57	2	C0520459
Disease	acute myeloid leukemia (is_implicated_in)	NF1 FGFR1 SOD2	5.83e-04	84	57	3	DOID:9119 (is_implicated_in)
Disease	Glioma	NF1 NTRK1 FGFR1	6.46e-04	87	57	3	C0017638
Disease	Deaf Mutism	PJVK CDC14A	6.81e-04	20	57	2	C4082305
Disease	Deafness, Acquired	PJVK CDC14A	6.81e-04	20	57	2	C0751068
Disease	Hearing Loss, Extreme	PJVK CDC14A	6.81e-04	20	57	2	C0086395
Disease	Complete Hearing Loss	PJVK CDC14A	6.81e-04	20	57	2	C0581883
Disease	Bilateral Deafness	PJVK CDC14A	6.81e-04	20	57	2	C3665473
Disease	Prelingual Deafness	PJVK CDC14A	6.81e-04	20	57	2	C0011052
Disease	Reperfusion Injury	TICAM1 NOS2 SOD2	6.90e-04	89	57	3	C0035126
Disease	Lewy Body Disease	NTRK1 SOD2	8.26e-04	22	57	2	C0752347
Disease	Behcet Syndrome	ITGB2 STAT4	9.85e-04	24	57	2	C0004943
Disease	Noonan Syndrome	NF1 A2ML1	9.85e-04	24	57	2	C0028326
Disease	Generalized seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C0234533
Disease	Clonic Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C0234535
Disease	Convulsive Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C0751494
Disease	Seizures, Sensory	REST NOS2 SOD2	9.96e-04	101	57	3	C0751496
Disease	Non-epileptic convulsion	REST NOS2 SOD2	9.96e-04	101	57	3	C0751056
Disease	Atonic Absence Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C0751123
Disease	Complex partial seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C0149958
Disease	Single Seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0751110
Disease	Nonepileptic Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C3495874
Disease	Visual seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0270824
Disease	Epileptic drop attack	REST NOS2 SOD2	9.96e-04	101	57	3	C0270846
Disease	Vertiginous seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0422855
Disease	Gustatory seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0422854
Disease	Seizures, Somatosensory	REST NOS2 SOD2	9.96e-04	101	57	3	C0422850
Disease	Olfactory seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0422853
Disease	Seizures, Auditory	REST NOS2 SOD2	9.96e-04	101	57	3	C0422852
Disease	Generalized Absence Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C4505436
Disease	Jacksonian Seizure	REST NOS2 SOD2	9.96e-04	101	57	3	C0022333
Disease	Epileptic Seizures	REST NOS2 SOD2	9.96e-04	101	57	3	C4317109
Disease	Absence Seizures	REST NOS2 SOD2	1.02e-03	102	57	3	C4316903
Disease	Convulsions	REST NOS2 SOD2	1.02e-03	102	57	3	C4048158
Disease	Tonic Seizures	REST NOS2 SOD2	1.02e-03	102	57	3	C0270844
Disease	Cerebral Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0750935
Disease	Intracranial Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0750936
Disease	Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0004114
Disease	Grade I Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0205768
Disease	Mixed oligoastrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0547065
Disease	Pilocytic Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0280783
Disease	Diffuse Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0280785
Disease	Deafness	PJVK CDC14A	1.07e-03	25	57	2	C0011053
Disease	Childhood Cerebral Astrocytoma	NF1 FGFR1	1.07e-03	25	57	2	C0338070
Disease	Seizures, Focal	REST NOS2 SOD2	1.08e-03	104	57	3	C0751495
Disease	Myoclonic Seizures	REST NOS2 SOD2	1.08e-03	104	57	3	C4317123
Disease	Tonic - clonic seizures	REST NOS2 SOD2	1.08e-03	104	57	3	C0494475
Disease	Heart valve disease	FGFR1 ITGB2	1.16e-03	26	57	2	C0018824
Disease	Gemistocytic astrocytoma	NF1 FGFR1	1.16e-03	26	57	2	C0334581
Disease	Protoplasmic astrocytoma	NF1 FGFR1	1.16e-03	26	57	2	C0334580
Disease	Fibrillary Astrocytoma	NF1 FGFR1	1.16e-03	26	57	2	C0334582
Disease	Anaplastic astrocytoma	NF1 FGFR1	1.25e-03	27	57	2	C0334579
Disease	obstructive sleep apnea (is_marker_for)	NTRK1 NOS2	1.44e-03	29	57	2	DOID:0050848 (is_marker_for)
Disease	Schizophrenia	SLC6A12 NTRK1 ERVK-8 SLC6A5 FGFR1 REST SOD2	1.51e-03	883	57	7	C0036341
Disease	Alzheimer's disease (is_marker_for)	NTRK1 CASP6 FGFR1 NOS2	1.55e-03	257	57	4	DOID:10652 (is_marker_for)
Disease	pulmonary sarcoidosis (is_marker_for)	NTRK1 NOS2	1.75e-03	32	57	2	DOID:13406 (is_marker_for)
Disease	Brain Tumor, Primary	ITGB2 SOD2	1.86e-03	33	57	2	C0750974
Disease	Primary malignant neoplasm of brain	ITGB2 SOD2	1.86e-03	33	57	2	C0750979
Disease	Recurrent Brain Neoplasm	ITGB2 SOD2	1.86e-03	33	57	2	C0750977
Disease	Benign neoplasm of brain, unspecified	ITGB2 SOD2	1.86e-03	33	57	2	C0496899
Disease	Neoplasms, Intracranial	ITGB2 SOD2	1.86e-03	33	57	2	C1527390

Protein segments in the cluster

Peptide	Gene	Start	Entry
EQPLQNFLCEGHVLP	CNPY4	176	Q8N129
LKKNRANICGQNPGP	CASS4	641	Q9NQ75
QQKRENVNPRHPCLG	ABCA4	1291	P78363
RLQQVLHAGSGPCLP	SERPINF2	131	P08697
CRPGSIIGPQQHFLE	CDC14A	311	Q9UNH5
FNCHLQEGAKGPLPV	CASR	356	P41180
HRLNGPLKCGQPQEV	A2ML1	456	A8K2U0
IPVVCHLPGVGQNLQ	CHDH	321	Q8NE62
HGPPNIVVAIAGNKC	RAB22A	106	Q9UL26
HPAQPLVLVGNKCDL	ERAS	141	Q7Z444
EHLGVCPGNQPALVQ	NOS2	771	P35228
LPQGKEPGLINLCAN	PAXIP1	281	Q6ZW49
ARQVHNGPKPLNCPH	REST	351	Q13127
PEQKLQCHGQGPLAH	NTRK1	171	P04629
GIDKPQCLAAHPVRG	LRP1B	1691	Q9NZR2
QGHLLLPGEQIQPKQ	MGA	2271	Q8IWI9
QACRGNQHDVPVIPL	CASP6	161	P55212
GLSCRALPGEQQPLH	IGFBP1	81	P08833
RQPQQVIHGEKLGLP	ITGA3	411	P26006
ARAEPGQPVHALQGC	EVPLL	176	A8MZ36
HLPTQEAGVNPRGLC	HERVK_113	631	P63132
HLPTQEAGVNPRGLC	ERVK-7	631	P63135
HLPTQEAGVNPRGLC	ERVK-6	631	Q9BXR3
TPHQRKGGPQSQLCD	PALLD	156	Q8WX93
ICLPAIGTGNAKQHP	PARP14	1326	Q460N5
ACPGLQLSNNPVKGR	ITGB2	646	P05107
LIGKDGQVHLQQRPC	C17orf99	161	Q6UX52
CLPRHPAQLANGGLK	FGFR1	806	P11362
CPSPINEHNGLIKGQ	FNDC3A	211	Q9Y2H6
KGNGSVCPQLLEPHR	P2RX5	406	Q93086
HLNCRLNGQAVKPLP	RUSC2	941	Q8N2Y8
GLLVLQNCPGPEHQS	SSPOP	1726	A2VEC9
HGNLGKACIPDTIPN	TADA2B	116	Q86TJ2
NALHCKIPFLRGPEG	SLC6A5	116	Q9Y345
IINHGPQIGECKINP	PKDREJ	556	Q9NTG1
QPKQHPCLDGSAGRN	SLC6A12	581	P48065
NVRLQCGENGPAHPL	TANC1	1606	Q9C0D5
CTPGQPGQQRVLHLE	MTG2	206	Q9H4K7
RGGHILPCQEPAQNT	SI	1686	P14410
GQTAILHCKVAGNPP	ROR2	76	Q01974
HPKQCHPALDGQRGK	IGFBP4	211	P22692
RVQKLCPGPQAHAVQ	SPTBN5	1901	Q9NRC6
HRPARQPQQGSGLCE	SSH1	551	Q8WYL5
FPLLINQPHKCRGDG	B3GNT9	96	Q6UX72
TLILPQHVNCPGGIN	ATRAID	121	Q6UW56
RPPGAQGLKNHGNTC	USP43	96	Q70EL4
QHFRKNHPGCIPLEG	ZBTB37	446	Q5TC79
RVNLLNHNIPKGPCI	PJVK	296	Q0ZLH3
NQGVCRPNGLKLNLP	STON1	31	Q9Y6Q2
RQQIACIGGPLHNGL	STAT4	241	Q14765
KTPRPGCQGQDLLHA	TICAM1	31	Q8IUC6
KNNVCVHPPEGLQGL	TBC1D16	41	Q8TBP0
QHRGQQPCPQEAGLI	PRRG2	136	O14669
HLPTQEAGVNPRGLC	ERVK-10	631	P10266
HLPTQEAGVNPRGLC	ERVK-8	631	P63133
LLLCNPRKQGPETQG	NF1	506	P21359
HLPTQEAGVNPRGLC	ERVK-11	631	Q9UQG0
RGHLQIAACPNQDPL	SOD2	156	P04179
PGNQPEKEGRAHQCL	ZNF236	1646	Q9UL36
VGVPEPGQLHFNQCL	SLC39A8	61	Q9C0K1
DCHGTGLQAIPKNIP	SLIT1	46	O75093
AHGLQHIGKRPFQCP	ZNF425	431	Q6IV72
RGPNVEAGCLNPHIV	SULF2	346	Q8IWU5
NNDFLCIHGGVPPRK	USP33	761	Q8TEY7
EKLQNCGVPEGHPVR	MYPN	1176	Q86TC9